The Lithium Comeback Wall Street Doesn't Trust

Welcome back to Alpha Stocks Daily 👋

While the market obsesses over AI chips, a very different kind of opportunity has been quietly staging a comeback in the most hated corner of the market: lithium. After two brutal years of collapsing prices, the world's premier lithium producer just posted a genuinely stunning turnaround swinging from a loss to a big profit and more than doubling its cash flow. And yet, right after that blowout, Wall Street lowered its price targets and the stock fell. That contradiction is exactly what makes today's pick worth understanding.

Today's ticker: Albemarle ($ALB) — the ~$15B critical-minerals giant that supplies the battery-grade lithium behind EVs and grid storage, with tier-1, low-cost assets in Chile and Australia. The cyclical recovery is real. The question is whether it lasts. Let's dig in. 👇

Here's the tension in one place. The consensus is a "Moderate Buy" across ~22 firms (13 Buy/Strong Buy, 9 Hold, 0 Sell), with an average 12-month target near $173 — roughly 30% above the ~$130 price. But note the enormous range ($83 low to $225 high) — that spread reflects total disagreement about where lithium prices go next.

Read this carefully: those are the moves that matter. Even after a blowout quarter, multiple desks lowered their targets and cut forward EPS estimates ~30%, and the stock fell ~6% in the days after. That's Wall Street saying, "great quarter — but we don't believe these lithium prices last." When analysts cut into a beat, pay attention.

Your portfolio could be losing more to taxes than you might realize. On September 17, Range's CFPs and CPAs share the portfolio moves that can help you maximize your after-tax returns — join us live, and bring your questions for Q&A.

Reserve your free spot

^{This webinar is for informational purposes only and does not constitute investment advice or a recommendation to buy, hold, or sell any security. Forward-looking statements involve risks and uncertainties. Past performance is not indicative of future results. Range defines "high earners" as households with income over $300k.}

Albemarle is the foundational supplier of the energy transition — it mines and refines the critical minerals inside every lithium-ion battery. Its moat is cost position: world-class, tier-1 resources that stay cash-generative even when prices crater. Three segments:

Its crown jewels are the Greenbushes hard-rock mine (Australia) and the Salar de Atacama brine operations (Chile) — among the lowest-cost lithium sources on Earth. Long-term contracts with automakers and battery makers add demand visibility. One important nuance: FY2026 volumes are guided to 225–235 kt LCE — roughly flat-to-down after a June fire at the Greenbushes/CGP3 plant (restarted Aug 1). So the recovery is being driven by price, not tonnage.

This is a commodity stock, so the macro is the thesis. The bullish setup right now is real: global lithium demand grew ~45% year-over-year through May, led by booming stationary storage (grid batteries), and industry inventories sit at near-record lows — a genuinely tight market that drove Albemarle's realized prices up 73%. Bromine is a bonus, with Middle East disruptions lifting pricing.

But the bear case is structural and never far away: lithium is notoriously oversupplied on any price spike, as low-cost Chinese and African lepidolite refiners flood back in when prices rise. Add resource nationalism in South America and China's grip on processing, and you get a commodity that can round-trip a rally fast. Albemarle's own guidance shows the leverage: full-year EBITDA could land anywhere from ~$0.9B to ~$4.4B depending purely on lithium prices. That range is the risk in a nutshell.

Albemarle's Q2 (reported Aug 5) was its best in years: net sales $1.7B (+31%), net income $480M ($3.52/share) versus a loss a year ago, adjusted EBITDA $858M (+155%, a 49% margin), and free cash flow of $638M at 83% cash conversion. Energy Storage EBITDA rocketed 229% on the price surge; Specialties rose 61%. The balance sheet is healthy (net debt/EBITDA of just 0.5x), and management even cut capex to ~$500M — disciplined, cash-focused execution.

Two things to weigh alongside the numbers: management raised its Specialties outlook (to $1.4–$1.6B sales) but kept total guidance scenario-based on lithium prices; and on September 3, Albemarle named Ragnar "Rag" Udd as its incoming CEO (effective Feb 1, 2027), replacing Kent Masters. A leadership transition mid-recovery is a wildcard worth watching.

Be clear-eyed here: despite the great quarter, ALB faded afterward and now trades around $126–$132, down ~6% in the days following earnings, with bearish options activity — the market digesting the "is it durable?" question. (52-week range: a very wide $71–$221, which tells you everything about this stock's volatility.)

Albemarle just proved the bull case can work: when lithium prices recover, this is a cost-advantaged cash machine, and Q2 (a $480M profit, 155% EBITDA growth, $638M of free cash flow) was a genuine turnaround, not a mirage. For investors who believe the EV and grid-storage buildout drives a multi-year lithium up-cycle, ALB is the highest-quality, lowest-cost way to own it — and it's still well off its highs.

But respect what the analysts are telling you by cutting targets into a beat: this rally is only as durable as lithium prices, and lithium has burned believers before. Volumes are flat, the guidance swings by billions on price alone, and a CEO change adds uncertainty. The whole trade comes down to one question: do lithium prices hold near current levels, or does oversupply return? If they hold, today's ~$130 looks cheap against $173+ targets. If they don't, cheap gets cheaper fast. A compelling, high-quality cyclical for believers — just size it knowing you're making a bet on a volatile commodity, not a steady compounder.

What we're watching next: spot lithium prices, the Greenbushes ramp back to full rate (Q1 2027), the CEO transition, and Q3 results (Nov 4).

Trade smart, size your risk, and we'll see you tomorrow. 🔋